2 Matching Annotations
  1. Sep 2021
  2. wwwnc.cdc.gov wwwnc.cdc.gov
    Predictors of Nonseroconversion after SARS-CoV-2 Infection - Volume 27, Number 9—September 2021 - Emerging Infectious Diseases journal - CDC
    1
    1. lucyparfitt16 01 Sep 2021

      Liu, W., Russell, R. M., Bibollet-Ruche, F., Skelly, A. N., Sherrill-Mix, S., Freeman, D. A., Stoltz, R., Lindemuth, E., Lee, F.-H., Sterrett, S., Bar, K. J., Erdmann, N., Gouma, S., Hensley, S. E., Ketas, T., Cupo, A., Cruz Portillo, V. M., Moore, J. P., Bieniasz, P. D., … Hahn, B. H. (2021). Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerging Infectious Diseases, 27(9), 2454–2458. https://doi.org/10.3201/eid2709.211042

      is:article lang:en seroconversion COVID-19 antibodies age science research vaccine protection predictor
    Visit annotations in context

    Tags

    Annotators

    URL

    wwwnc.cdc.gov/eid/article/27/9/21-1042_article
  3. twitter.com twitter.com
    Hannah Davis 🌈 on Twitter
    1
    1. lucyparfitt16 01 Sep 2021

      Hannah Davis 🌈 on Twitter: “New CDC study finds that 36% of COVID patients never seroconvert, meaning they NEVER make antibodies! #LongCovid This is a huge finding which we need to amplify broadly! Please retweet & send to providers, patients, support groups, #MedTwitter, etc. Https://t.co/gEne4dE0TQ 1/” / Twitter. (n.d.). Retrieved September 1, 2021, from https://twitter.com/ahandvanish/status/1432411002688184320?s=20

      is:tweet lang:en CDC Centers for Disease Control and Prevention COVID-19 antibodies research seroconversion science long covid protection vaccine efficacy reinfection vaccine
    Visit annotations in context

    Tags

    Annotators

    URL

    twitter.com/ahandvanish/status/1432411002688184320